|

[177Lu]Lu-SN201 Clinical Trials

1 actively recruiting trial

Also known as: Tumorad

Pipeline

Phase 1/2: 1

Top Sponsors

  • Spago Nanomedical AB1

Indications

  • Recurrent Solid Tumor1
  • Refractory Cancer1
  • Locally Advanced Solid Tumor1
  • Unresectable Solid Tumor1
  • Metastatic Cancer1

Other1 trial

A Dose Escalation and Expansion Study of [177Lu]Lu-SN201 in Participants With Advanced Cancer
Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.